CD4+ T-helper cells stimulated in response to placental ischemia mediate hypertension during pregnancy

Hypertension

Volumn 57, Issue 5, 2011, Pages 949-955

  Wallace, Kedra ^a   Richards, Sarah ^a   Dhillon, Pushpinder ^a   Weimer, Abram ^a   Edholm, Eva Stina ^b   Bengten, Eva ^b   Wilson, Melanie ^b   Martin, James N ^a   Lamarca, Babbette ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

angiogenesis; cytokines; hypertension; inflammation; pregnancy

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN RECEPTOR 1;

ADOPTIVE TRANSFER; ANGIOGENESIS; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ARTERY CATHETER; ARTICLE; BLOOD LEVEL; CD4+ T LYMPHOCYTE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATION PERIOD; IMMUNE RESPONSE; ISCHEMIA; MATERNAL HYPERTENSION; MEAN ARTERIAL PRESSURE; NONHUMAN; PATHOPHYSIOLOGY; PERFUSION PRESSURE; PLACENTA ISCHEMIA; PRIORITY JOURNAL; RAT; REDUCED UTERINE PERFUSION PRESSURE; SPLEEN; T LYMPHOCYTE ACTIVATION;

ANALYSIS OF VARIANCE; ANIMALS; BLOOD PRESSURE; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HYPERTENSION, PREGNANCY-INDUCED; INFLAMMATION; ISCHEMIA; PLACENTA; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; SPLEEN; T-LYMPHOCYTES, HELPER-INDUCER; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 79955475827     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.110.168344     Document Type: Article

References (22)

1. Noris M, Perico N, Remuzzi G. Mechanisms of disease: Preeclampsia. Nat Clin Prac Nephrology. 2005;1:98-114.
2. Roberts J, Pearson G, Cutler J, Lindheimer M. Summary of the NHLBI working group on research on hypertension during pregnancy. Hypertension. 2003;41:437-445. (Pubitemid 36314613)
3. Roberts J, Lain K. Recent Insights into the pathogenesis of preeclampsia. Placenta. 2002;23:359-372.
4. Lindheimer M, Romero R. Emerging roles of antiangiogenic and angiogenic proteins in the pathogenesis and prediction of preeclampsia. Hypertension. 2007;50:35-36. (Pubitemid 46986005)
5. Thadhani R, Johnson R, Karumanchi S. Hypertension during pregnancy: a disorder begging for pathophysiological support. Hypertension. 2005; 46:1250-1251. (Pubitemid 43189715)
6. Benyo D, Miles T, Conrad K. Hypoxia stimulates cytokine production by villous explants from the human placenta. J Clin Endocrinol Metab. 1997;82:1582-1588. (Pubitemid 27200438)
7. Conrad K, Benyo D. Placental cytokines and the pathogenesis of Preeclampsia. Am J Reprod Immunol. 1997;37:240-249. (Pubitemid 27149786)
8. Santner-Nanan B, Peek M, Khanam R, Richarts L, Zhu E, Fazekas de St Groth B, Nanan R. Systemic increase in the ration between FoxP3 + and IL-17 producing CD4+ T cells in healthy pregnancy but not in Preeclampsia. J Immunol. 2009;183:7023-7030.
9. Sargent I, Borzychowski A, Redman C Immunoregulation in normal pregnancy and preeclampsia: an overview. Reproductive Biomed Online. 2006;13:680-686. (Pubitemid 44760892)
10. Prins J, Boelens H, Heimweg J, Van der Heide S, Dubois A, Van Oosterhout A, Erwich J. Preeclampsia is associated with lower per-centages of regulatory T cells in maternal blood. Hypertens Pregnancy. 2009;28:300-311.
11. Abbus A. Cellular and Molecular Immunology. Philadelphia, PA: Elsevier; 2005.
12. Cruse J, Lewis R. Illustrated Dictionary of Immunology. 3rd ed. Boca Raton, FL: CRC Press; 2009.
13. Alexander B, Kassab S, Miller M, Abram S, Reckelhoff J, Bennett W, Granger J. Reduced uterine perfusion pressure during pregnancy in the rat is associated with increases in arterial pressure and changes in renal nitric oxide. Hypertension. 2001;37:1191-1195. (Pubitemid 32304024)
14. Granger J, LaMarca B, Cockrell K, Sedeek M, Balzi C, Chandler D, Bennett W. Reduced uterine perfusion pressure (RUPP) model for studying cardiovascular-renal dysfunction in response to placental ische-mia. Methods Mol Med. 2006;122:383-392.
15. LaMarca B. The role of immune activation in contributing to vascular dysfunction and the pathophysiology of hypertension during Preeclampsia. Minerva Ginecol. 2010;62:105-120.
16. LaMarca B, Speed J, Fournier L, Babcock S, Berry H, Cockrell K, Granger J. Hypertens in response to chronic reductions in uterine perfusion in pregnant rats: effect of tumor necrosis factor-α blockade. Hypertension. 2008;52:1161-1167.
17. LaMarca B, Bennett W, Alexander B, Cockrell K, Granger J. Hypertens produced by reductions in uterine perfusion in the pregnant rat: role of tumor necrosis factor-a. Hypertension. 2005;46:1022-1025.
18. LaMarca B, Alexander B, Gilbert J, Ryan M, Sedeek M, Granger J. Pathophysiology of hypertension in response to placental ischemia during pregnancy: a central role for endothelin? Gend Med. 2008;5: S133-S138. (Pubitemid 351455238)
19. Zenclussen AC, Fest S, Joachim R, Klapp BF, Arck PC Introducing a mouse model for Preeclampsia: adoptive transfer of activated Th1 cells leads to Preeclampsia-like symptoms exclusively in pregnant mice. Eur J Immunol. 2004;34:377-387. (Pubitemid 39255948)
20. LaMarca B, Ryan M, Gilbert J, Murphy S, Granger J. Inflammatory cytokines in the pathophysiology of hypertension during preeclampsia. Curr Hypertens Rep. 2007;9:480-485.
21. Parrish M, Murphy S, Rutland S, Wallace K, Wenzel K, Wallukat G, Keiser S, Ray L, Dechend R, Martin J, Granger J, LaMarca B. The effect of immune factors, tumor necrosis factor-α, and agonistic autoantibodies to the angiotensin II type I recpetor on soluble fms-like tyrosine-1 and soluble endoglin production in response to hypertension during pregnancy. Am J Hypertens. 2010;23:911-916.
22. Cockell A, Learmont J, Smarason A, Redman C, Sargent I, Poston L. Human placental synctiotrophoblast microvillous membranes impair maternal vascular endothelial function. Br J Obstet Gynaecol. 1997;104: 235-240. (Pubitemid 27065151)